Articles

REKOMBINANT OQSILLAR ASOSIDA MAHALLIY DORI VOSITALARINI ISHLAB CHIQARISH

Vol. 3 No. 6 (2026): Журнал академических исследований Нового Узбекистана 121-123

DOI: 10.5281/zenodo.20725536 2026-06-17 Articles Open Access

Authors

  • Otaxonova Dilnoza

Abstract

Ushbu maqolada rekombinant DNK texnologiyasi yordamida terapevtik oqsillarni ishlab chiqarish jarayoni, ekspressiya tizimlari va O'zbekiston sharoitida mahalliy dori vositalarini yaratish istiqbollari ko'rib chiqiladi. Insulin, o'sish gormoni va antikorlar kabi rekombinant mahsulotlarni ishlab chiqarish bosqichlari, tozalash usullari va sifat nazorati masalalari tahlil etiladi.

References

Walsh G. Biopharmaceuticals: Biochemistry and Biotechnology. — Wiley, 2014.

Demain A.L., Vaishnav P. Production of Recombinant Proteins by Microbes and Higher Organisms. — Biotechnology Advances, 2009.

Yusupov T. Gen muhandisligi va rekombinant oqsillar texnologiyasi. — Toshkent: Fan, 2018.

Karimova D. Pichia pastoris asosida terapevtik oqsillar ishlab chiqarish. — Toshkent: O'zbekiston, 2020.

Rashidova S. Kodon optimallashtirish va gen ekspressiyasi samaradorligi. — Toshkent: TDAU, 2019.

Tursunov B. Rekombinant oqsillarni tozalash texnologiyalari. — Toshkent: Fan, 2021.

Karimov SH. Biofarmatsevtik mahsulotlar uchun sifat nazorati. — Toshkent: TDTU, 2020.

Xolmatov B. Mahalliy biofarmatsevtika sanoatini rivojlantirish istiqbollari. — Toshkent: TDPU, 2022.

Downloads

Published

2026-06-17

How to Cite

Otaxonova, D. (2026). REKOMBINANT OQSILLAR ASOSIDA MAHALLIY DORI VOSITALARINI ISHLAB CHIQARISH . New Uzbekistan Journal of Academic Research, 3(6), 121-123. https://doi.org/10.5281/zenodo.20725536
Innovative Academy RSC
Article metrics Views and PDF downloads
2 Views
0 Downloads